ARTHUR B LAFFER
CIK 1090307 · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.36M
Companies
9
Total Filings
111
Lifetime Open-Market Net
$2.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NXDTpA | Director | 256,488 | $13.29 | $3.41M | $689.0K | 19 | 2026-06-12 |
| NXRT | Director | 58,385 | $28.72 | $1.68M | $720.6K | 29 | 2026-05-27 |
| NREFpA | Director | 65,009 | $24.05 | $1.56M | $0 | 10 | 2026-04-06 |
| VerifyMe, Inc. (VRMEW) Delisted | Director | 390,835 | $0.01 | $5.4K | $84.7K | 19 | 2025-03-11 |
| NREF | Director | 39,700 | $15.87 | $630.0K | $754.2K | 3 | 2020-05-11 |
| JOB | Director | 375,873 | $0.23 | $86.1K | $324.3K | 5 | 2018-06-28 |
| NIVS IntelliMedia Technology Group, Inc. (NIV) Delisted | Director | — | — | — | $0 | 1 | 2010-05-06 |
| MPS GROUP INC (MPS) Delisted | Director | 0 | — | — | -$301.6K | 6 | 2010-01-19 |
| Oncotelic Therapeutics, Inc. (OXGN) Delisted | Director | 409,232 | — | — | $0 | 4 | 2010-01-05 |
Recent Filings · Page 11 of 12
111 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-05-06 | NIVS IntelliMedia Technology Group, Inc. (NIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-01-19 | MPS GROUP INC (MPS) Delisted | Disp (D) | −145,146 | -$2.00M | EDGAR |
| 2010-01-05 | Oncotelic Therapeutics, Inc. (OXGN) Delisted | Grant (A) | +43,662 | $49.8K | EDGAR |
| 2010-01-04 | MPS GROUP INC (MPS) Delisted | Mixed | +46,896 | $20 | EDGAR |
| 2009-12-10 | Oncotelic Therapeutics, Inc. (OXGN) Delisted | Grant (A) | +30,000 | $34.2K | EDGAR |
| 2009-10-05 | Oncotelic Therapeutics, Inc. (OXGN) Delisted | Grant (A) | +5,369 | $7.6K | EDGAR |
| 2009-09-18 | Oncotelic Therapeutics, Inc. (OXGN) Delisted | Grant (A) | +20,061 | $18.5K | EDGAR |
| 2009-02-19 | MPS GROUP INC (MPS) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2008-03-31 | MPS GROUP INC (MPS) Delisted | Sell (S) | −25,000 | -$301.6K | EDGAR |
| 2008-02-21 | MPS GROUP INC (MPS) Delisted | Grant (A) | +21,250 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.